home / stock / jazz / jazz news


JAZZ News and Press, Jazz Pharmaceuticals plc From 05/01/24

Stock Information

Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com

Menu

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...

JAZZ - Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript

2024-05-01 20:46:08 ET Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Conference Call May 01, 2024 4:30 PM ET Company Participants Andrea Flynn – Vice President and Head-Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Ren&#x...

JAZZ - Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook

2024-05-01 16:23:44 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (up...

JAZZ - Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference

Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference PR Newswire DUBLIN , May 1, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Gl...

JAZZ - Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance PR Newswire – 12% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – On...

JAZZ - Expected US Company Earnings on Wednesday, May 1st, 2024

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

JAZZ - Jazz Pharmaceuticals Q1 2024 Earnings Preview

2024-04-30 17:20:33 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off Jazz Pharmaceuticals PLC (JAZZ) Q4 2023 Earnings Call Transcript Avadel surges afte...

JAZZ - Harmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)

2024-04-30 16:00:00 ET Summary Harmony Biosciences Holdings, Inc. stock price fell sharply in October last year, as the lead drug pitolisant - approved to treat narcolepsy - missed endpoints in a late stage IH study. The company's Q3 2023 earnings saw Wakix revenues up 37% YoY and...

JAZZ - Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month

NORTHAMPTON, MA / ACCESSWIRE / April 30, 2024 / Jazz Pharmaceuticals: At Jazz, Earth Month provides an opportunity to reflect on steps we can take to become more conscious of our actions to positively impact the planet. For more information on our approach to sustainable practices, read our Co...

JAZZ - Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024

Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 PR Newswire Overall survival and additional long-term follow-up data from the Phase 2b HERIZON-BTC-01 trial in previously treated HER2-positive metastatic biliary tract cancer ...

JAZZ - Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community

Originally published by Jazz Pharmaceuticals NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face when living with the condition. Jazz wants the epilepsy community know that they are not alone and showed support by sporting pu...

Previous 10 Next 10